<- Go Home
Vaso Corporation
Vaso Corporation, together with its subsidiaries, operates in the healthcare equipment and information technology industries in the United States and internationally. It operates in three segments: IT, Professional Sales Service, and Equipment. The IT segment primarily focuses on healthcare IT and managed network technology services. This segment offers managed healthcare software solutions, including diagnostic imaging applications; managed network infrastructure, such as routers, switches, and other equipment; managed network transport; and managed network security services. The Professional Sales Service segment principally focuses on the sale of healthcare capital equipment for General Electric Healthcare, Inc. (GEHC) into the health provider middle market. Its offerings include GEHC diagnostic imaging equipment and ultrasound systems, GEHC service agreements, GEHC training, and GEHC and third-party financial services. The Equipment segment primarily focuses on the design, manufacture, sale, and service of proprietary medical devices and software. This segment offers Biox series Holter monitors and ambulatory blood pressure recorders; ARCS series analysis, reporting, and communication software for ECG and blood pressure signals, including cloud-based software and algorithm subscription services; MobiCare multi-parameter wireless vital-sign monitoring systems; and Enhanced External Counterpulsation therapy systems for non-invasive and outpatient treatment of ischemic heart disease. The company was formerly known as Vasomedical, Inc. and changed its name to Vaso Corporation in November 2016. Vaso Corporation was incorporated in 1987 and is headquartered in Plainview, New York.
Market Cap
$21.6M
Volume
142.9K
Cash and Equivalents
$25.3M
EBITDA
$3.1M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$52.5M
Profit Margin
59.99%
52 Week High
$0.32
52 Week Low
$0.11
Dividend
N/A
Price / Book Value
0.81
Price / Earnings
20.59
Price / Tangible Book Value
2.32
Enterprise Value
-$1.5M
Enterprise Value / EBITDA
-0.37
Operating Income
$2.3M
Return on Equity
4.02%
Return on Assets
1.98
Cash and Short Term Investments
$25.3M
Debt
$2.1M
Equity
$26.6M
Revenue
$87.5M
Unlevered FCF
-$1.5M
Sector
Health Care Equipment and Supplies
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium